Numeric Investors’s Meridian Bioscience Inc VIVO Stock Holding History

Numeric Investors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$2.24M	Buy	159,963 +44,200	+38%	+$647K	0.02%	606
2017 Q3	$1.66M	Buy	115,763 +60,463	+109%	+$864K	0.01%	639
2017 Q2	$871K	Buy	55,300 +10,500	+23%	+$151K	0.01%	709
2017 Q1	$618K	Buy	44,800 +16,500	+58%	+$231K	0.01%	748
2016 Q4	$501K	Sell	28,300 -12,900	-31%	-$227K	﹤0.01%	830
2016 Q3	$795K	Sell	41,200 -20,200	-33%	-$395K	0.01%	674
2016 Q2	$1.2M	Sell	61,400 -14,200	-19%	-$278K	0.01%	538
2016 Q1	$1.56M	Buy	75,600 +25,900	+52%	+$510K	0.02%	477
2015 Q4	$1.02M	Buy	49,700 +18,700	+60%	+$359K	0.01%	585
2015 Q3	$530K	Buy	+31,000	New	+$567K	0.01%	686

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Numeric Investors's VIVO Position: Q4 2017 in Review

Numeric Investors increased its Meridian Bioscience Inc (VIVO) stake by 38% in Q4 2017, buying an estimated $647K and bringing the position to 159,963 shares worth $2.24M. The position accounts for 0.02% of the portfolio, ranked #606.

Numeric Investors first reported a position in VIVO in Q3 2015 and has held it in 10 quarters since. 178 funds tracked by Wall St. Rank hold VIVO as of Q4 2017.

Numeric Investors held 159,963 shares of Meridian Bioscience Inc worth $2.24M as of Q4 2017.
Numeric Investors bought 44,200 Meridian Bioscience Inc shares in Q4 2017, an estimated $647K.
Meridian Bioscience Inc made up 0.02% of Numeric Investors's portfolio in Q4 2017, its #606 holding.
Numeric Investors first reported a position in Meridian Bioscience Inc in Q3 2015 and has held it in 10 quarters since.
178 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.